JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 11 1657-1666
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Podreka, I.
Right arrow Articles by Deecke, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Podreka, I.
Right arrow Articles by Deecke, L.

Initial Experience with Technetium-99m HM-PAO Brain SPECT

I. Podreka, E. Suess, G. Goldenberg, M. Steiner, T. Brücke, Ch. Müller, W. Lang, R.D. Neirinckx and L. Deecke

Abteilung für Neuronuklearmedizin der Neurologischen Universitätsklinik Wien, Vienna, Austria
Amersham International, Buckinghamshire, United Kingdom

Correspondence: For reprints contact: Doz. Dr. Ivo Podreka, Neurologische Universitätsklinik Wien, Lazarettgasse 14, A-1090 Vienna, Austria.

ABSTRACT

Technetium-99m hexamethylpropyleneamineoxime ([99mTc]HM-PAO) brain single photon emission computed tomography (SPECT) was performed with a dual head rotating scintillation camera. Normal tracer distribution and side/side differences of counting rates were obtained in 11 healthy volunteers. Almost stable gray/white matter ratios were found (1.97–2.1) in one normal subject during 2 hr after tracer administration. Eighty-three investigated patients had the following diagnoses (in parentheses is percent of positive findings in each group): cerebral vascular disease 18 (94.4%), epilepsy 23 (82.6%), extrapyramidal disorders 8 (100%), dementia 12 (100%), headache 11 (63.6%), psychiatric disorders 11 (27.3%). In addition, SPECT was performed in 28 male volunteers during motor or visual imagery tasks and a significant increase (p = 0.035) of relative tracer deposition was observed in the left inferior occipital region during visual imagery when compared with motor imagery. The results indicate that [99mTc]HM-PAO SPECT is valuable for demonstrating pathologic and physiologic changes of the brain.




This article has been cited by other articles:


Home page
StrokeHome page
Y. Komaba, M. Mishina, K. Utsumi, Y. Katayama, S. Kobayashi, and O. Mori
Crossed Cerebellar Diaschisis in Patients With Cortical Infarction: Logistic Regression Analysis to Control for Confounding Effects
Stroke, February 1, 2004; 35(2): 472 - 476.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Rosenow and H. Luders
Presurgical evaluation of epilepsy
Brain, September 1, 2001; 124(9): 1683 - 1700.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Berrouschot, H. Barthel, S. Hesse, W. H. Knapp, D. Schneider, and R. von Kummer
Reperfusion and Metabolic Recovery of Brain Tissue and Clinical Outcome After Ischemic Stroke and Thrombolytic Therapy
Stroke, July 1, 2000; 31(7): 1545 - 1551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N. Miyazawa, M. Uchida, A. Fukamachi, I. Fukasawa, H. Sasaki, and H. Nukui
Xenon Contrast-Enhanced CT Imaging of Supratentorial Hypoperfusion in Patients with Brain Stem Infarction
AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1858 - 1862.
[Abstract] [Full Text]


Home page
StrokeHome page
J. Berrouschot, H. Barthel, J. Koster, S. Hesse, A. Rossler, W. H. Knapp, and D. Schneider
Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke : A Randomized Pilot Study
Stroke, April 1, 1999; 30(4): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Berrouschot, H. Barthel, R. von Kummer, W. H. Knapp, S. Hesse, and D. Schneider
99mTechnetium-Ethyl-Cysteinate-Dimer Single-Photon Emission CT Can Predict Fatal Ischemic Brain Edema
Stroke, December 1, 1998; 29(12): 2556 - 2562.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J V Bowler, J P H Wade, B E Jones, K S Nijran, and T J Steiner
Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT
J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 90 - 97.
[Abstract] [Full Text]


Home page
StrokeHome page
B. Infeld, S. M. Davis, G. A. Donnan, M. Lichtenstein, A. E. Baird, D. Binns, P. J. Mitchell, and J. L. Hopper
Streptokinase Increases Luxury Perfusion After Stroke
Stroke, September 1, 1996; 27(9): 1524 - 1529.
[Abstract] [Full Text]


Home page
StrokeHome page
P. Laloux, J. Jamart, H. Meurisse, P. De Coster, and C. Laterre
Persisting Perfusion Defect in Transient Ischemic Attacks : A New Clinically Useful Subgroup?
Stroke, March 1, 1996; 27(3): 425 - 430.
[Abstract] [Full Text]


Home page
StrokeHome page
P. Laloux, F. Richelle, J. Jamart, P. De Coster, and C. Laterre
Comparative Correlations of HMPAO SPECT Indices, Neurological Score, and Stroke Subtypes With Clinical Outcome in Acute Carotid Infarcts
Stroke, May 1, 1995; 26(5): 816 - 821.
[Abstract] [Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
A. O. Tascioglu and T. Aras
Baseline and Post-Acetazolamide SPECT Evaluation of Carotid Endarterectomy Cases: Basis for Selection of Patients for Surgery and for Assessment of Efficiency of Surgery
Vascular and Endovascular Surgery, September 1, 1993; 27(7): 481 - 490.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. Legido, M. L. Price, B. Wolfson, E. N. Faerber, C. Foley, D. Miles, and W. D. Grover
Technetium 99mTc-HMPAO SPECT in Children and Adolescents With Neurologic Disorders
J Child Neurol, July 1, 1993; 8(3): 227 - 234.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.